Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia

Bone Marrow Transplantation

Volumn 35, Issue 10, 2005, Pages 991-995

  Berger, Claire ^a   Le Gallo, B ^a   Donadieu, J ^b   Richard, O ^a   Devergie, A ^c   Galambrun, C ^d   Bordigoni, P ^e   Vilmer, E ^f   Plouvier, E ^g   Perel, Y ^h   Michel, G ⁱ   Stephan, J L ^a  

^a HÔPITAL NORD   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL DEBROUSSE   (France)

^e CHU NANCY BRABOIS   (France)

^f HÔPITAL ROBERT DEBRÉ   (France)

^g HÔPITAL SAINT JACQUES   (France)

^h BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁱ Hopital Nord   (France)

Author keywords

ALL; Children; Thyroid dysfunction

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CYTOLOGY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROID FUNCTION; THYROID NODULE; WHOLE BODY RADIATION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPOTHYROIDISM; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; RISK FACTORS; SURVIVORS; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 21044455289     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704945     Document Type: Article

References (12)

1. Collet D. Modelling Survival Data in Medical Research. Chapman & Hall: London, 1994.
2. Schemper M, Stare J. Explained variation in survival analysis. Stat Med 1996; 19: 1999-2012.
3. Pasqualini T, McCalla J, Berg S et al. Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukaemia. Acta Endocrinol (Copenh) 1991; 124: 375-380.
4. Boulad F, Bromley M, Black P et al. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995; 15: 71-76.
5. Borgström B, Bolme P. Thyroid function in children after allogenic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 59-64.
6. Thomas BC, Stanhope R, Plowman PN et al. Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinol 1993; 128: 508-512.
7. Sanders JE, and the long term follow-up team. Endocrine problems in children after bone marrow transplant for hematologic malignancies. Bone Marrow Transplant 1991; 8: 2-4.
8. Michel G, Socié G, Gebhard F et al. Late effects of allogenic bone marrow transplantation for children with acute myeloblastic leukaemia in first complete remission: the impact of conditioning regimen without total body irradiation, a report from the Société Française de Greffe de Moelle. J Clin Oncol 1997; 15: 335-340.
9. Katsanis E, Shapiro RS, Robinson LL et al. Thyroid dysfunction following bone marrow transplantation: long term follow-up of 80 pediatric patients. Bone Marrow Transplant 1990; 5: 335-340.
10. Toubert ME, Socié G, Gluckman E et al. Short and long-term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation. Br J Haematol 1997; 98: 453-457.
11. Thuret I, Michel G, Carla H et al. Long term side-effects in children receiving allogeneic bone marrow transplantation in first complete remission of acute leukaemia. Bone Marrow Transplant 1995; 15: 337-341.
12. Cohen A, Rovelli A, Van Lint MT et al. Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant 2001; 28: 1125-1128.